350 related articles for article (PubMed ID: 21742975)
1. 4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection.
Vezys V; Penaloza-MacMaster P; Barber DL; Ha SJ; Konieczny B; Freeman GJ; Mittler RS; Ahmed R
J Immunol; 2011 Aug; 187(4):1634-42. PubMed ID: 21742975
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.
Blackburn SD; Crawford A; Shin H; Polley A; Freeman GJ; Wherry EJ
J Virol; 2010 Feb; 84(4):2078-89. PubMed ID: 19955307
[TBL] [Abstract][Full Text] [Related]
4. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection.
Penaloza-MacMaster P; Kamphorst AO; Wieland A; Araki K; Iyer SS; West EE; O'Mara L; Yang S; Konieczny BT; Sharpe AH; Freeman GJ; Rudensky AY; Ahmed R
J Exp Med; 2014 Aug; 211(9):1905-18. PubMed ID: 25113973
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.
West EE; Jin HT; Rasheed AU; Penaloza-Macmaster P; Ha SJ; Tan WG; Youngblood B; Freeman GJ; Smith KA; Ahmed R
J Clin Invest; 2013 Jun; 123(6):2604-15. PubMed ID: 23676462
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
7. Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model.
Lukens JR; Cruise MW; Lassen MG; Hahn YS
J Immunol; 2008 Apr; 180(7):4875-84. PubMed ID: 18354211
[TBL] [Abstract][Full Text] [Related]
8. Reviving exhausted T lymphocytes during chronic virus infection by B7-H1 blockade.
Yao S; Chen L
Trends Mol Med; 2006 Jun; 12(6):244-6. PubMed ID: 16650803
[TBL] [Abstract][Full Text] [Related]
9. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.
Clouthier DL; Zhou AC; Watts TH
J Immunol; 2014 Nov; 193(10):5033-43. PubMed ID: 25281716
[TBL] [Abstract][Full Text] [Related]
10. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
[TBL] [Abstract][Full Text] [Related]
11. Restoring function in exhausted CD8 T cells during chronic viral infection.
Barber DL; Wherry EJ; Masopust D; Zhu B; Allison JP; Sharpe AH; Freeman GJ; Ahmed R
Nature; 2006 Feb; 439(7077):682-7. PubMed ID: 16382236
[TBL] [Abstract][Full Text] [Related]
12. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination.
Tan JT; Whitmire JK; Murali-Krishna K; Ahmed R; Altman JD; Mittler RS; Sette A; Pearson TC; Larsen CP
J Immunol; 2000 Mar; 164(5):2320-5. PubMed ID: 10679066
[TBL] [Abstract][Full Text] [Related]
13. 4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilitates Tumor Abrogation.
Qu QX; Zhu XY; Du WW; Wang HB; Shen Y; Zhu YB; Chen C
Front Immunol; 2020; 11():577. PubMed ID: 32391001
[TBL] [Abstract][Full Text] [Related]
14. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
15. CD4 T Cell Depletion Substantially Augments the Rescue Potential of PD-L1 Blockade for Deeply Exhausted CD8 T Cells.
Penaloza-MacMaster P; Provine NM; Blass E; Barouch DH
J Immunol; 2015 Aug; 195(3):1054-63. PubMed ID: 26116499
[TBL] [Abstract][Full Text] [Related]
16. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver.
Maier H; Isogawa M; Freeman GJ; Chisari FV
J Immunol; 2007 Mar; 178(5):2714-20. PubMed ID: 17312113
[TBL] [Abstract][Full Text] [Related]
17. c-IAP ubiquitin protein ligase activity is required for 4-1BB signaling and CD8(+) memory T-cell survival.
Giardino Torchia ML; Munitic I; Castro E; Herz J; McGavern DB; Ashwell JD
Eur J Immunol; 2015 Sep; 45(9):2672-82. PubMed ID: 26096449
[TBL] [Abstract][Full Text] [Related]
18. Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell Exhaustion.
Condotta SA; Khan SH; Rai D; Griffith TS; Badovinac VP
J Immunol; 2015 Jul; 195(1):116-25. PubMed ID: 25980007
[TBL] [Abstract][Full Text] [Related]
19. Striking dichotomy of PD-L1 and PD-L2 pathways in regulating alloreactive CD4(+) and CD8(+) T cells in vivo.
Habicht A; Kewalaramani R; Vu MD; Demirci G; Blazar BR; Sayegh MH; Li XC
Am J Transplant; 2007 Dec; 7(12):2683-92. PubMed ID: 17924994
[TBL] [Abstract][Full Text] [Related]
20. Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model.
Durgan K; Ali M; Warner P; Latchman YE
Cancer Immunol Immunother; 2011 Apr; 60(4):547-58. PubMed ID: 21240487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
